These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7116756)

  • 1. Effects of pindolol on renal function II. Effects on intravenous and prolonged oral dosing.
    Boner G; Wainer E; Rosenfeld JB
    Clin Pharmacol Ther; 1982 Oct; 32(4):423-7. PubMed ID: 7116756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pindolol on renal function.
    Wainer E; Boner G; Rosenfeld JB
    Clin Pharmacol Ther; 1980 Nov; 28(5):575-80. PubMed ID: 7002425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal function during acute and long term pindolol treatment in hypertensive patients with normal and decreased glomerular filtration.
    Rosenfeld J; Boner G; Wainer E
    Br J Clin Pharmacol; 1982; 13(Suppl 2):237S-240S. PubMed ID: 7104147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute renal effects of beta-blockers.
    Zech P; Pozet N; Labeeuw M; Laville M; Hadj-Aissa A; Arkouche W; Poncet JF
    Am J Nephrol; 1986; 6 Suppl 2():15-9. PubMed ID: 2879466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous administration of a cocktail of markers to measure renal drug elimination pathways: absence of a pharmacokinetic interaction between fluconazole and sinistrin, p-aminohippuric acid and pindolol.
    Gross AS; McLachlan AJ; Minns I; Beal JB; Tett SE
    Br J Clin Pharmacol; 2001 Jun; 51(6):547-55. PubMed ID: 11422014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic and renal vasodilation after beta-adrenoceptor blockade with pindolol: a hemodynamic study on the onset and maintenance of its antihypertensive effect.
    van den Meiracker AH; Man in 't Veld AJ; Ritsema van Eck HJ; Schalekamp MA
    Am Heart J; 1986 Aug; 112(2):368-74. PubMed ID: 2874735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of IGF-I on renal function in end-stage chronic renal failure.
    Miller SB; Moulton M; O'Shea M; Hammerman MR
    Kidney Int; 1994 Jul; 46(1):201-7. PubMed ID: 7933838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of pindolol and propranolol on renal function of patients with hypertension.
    Pasternack A; Pörsti P; Pöyhönen L
    Br J Clin Pharmacol; 1982; 13(Suppl 2):241S-244S. PubMed ID: 7104148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal hemodynamics and pharmacokinetics of bevantolol in patients with impaired renal function.
    Solimon M; Massry SG; Campese VM
    Am J Cardiol; 1986 Nov; 58(12):21E-24E. PubMed ID: 2878596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of IGF-I on renal function in patients with chronic renal failure.
    O'Shea MH; Miller SB; Hammerman MR
    Am J Physiol; 1993 May; 264(5 Pt 2):F917-22. PubMed ID: 8498545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of local infusion of adenosine in man.
    Edlund A; Ohlsén H; Sollevi A
    Clin Sci (Lond); 1994 Aug; 87(2):143-9. PubMed ID: 7924159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pindolol on renal function in hypertensive patients.
    Gafter U; Holtzman E; Rosenthal T; Stern N; Zevin D; Levi J
    Isr J Med Sci; 1983 Jun; 19(6):563-5. PubMed ID: 6862866
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic effects of pindolol and atenolol at rest and during isometric exercise: a noninvasive study with healthy volunteers.
    Rapola JM; Pellinen TJ; Koskinen P; Toivonen L; Nieminen MS
    Cardiovasc Drugs Ther; 1990 Jun; 4(3):737-43. PubMed ID: 2076384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of intravenous and oral pindolol in hypertensive patients with chronic renal failure.
    Safar ME; Chau NP; Levenson JA; Simon AC; Weiss YA
    Clin Sci Mol Med Suppl; 1978 Dec; 4():275s-277s. PubMed ID: 282067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal function and hemodynamic studies in low- and normal-renin essential hypertension.
    Bauer JH; Brooks CS; Burch RN
    Arch Intern Med; 1982 Jul; 142(7):1317-23. PubMed ID: 7046671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Therapy with ACE inhibitors in chronic heart failure and limited kidney function].
    Osterziel KJ; Nagel F; Dietz R
    Z Kardiol; 1994; 83 Suppl 4():81-7. PubMed ID: 7856286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Responses of glomerular filtration, renal blood flow and salt-water handling to acute cardioselective and non-selective beta-adrenoceptor blockade in essential hypertension.
    Koch G; Fransson L; Karlegärd L; Kothari P
    Eur J Clin Pharmacol; 1989; 36(4):343-5. PubMed ID: 2567670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of tenoxicam on renal function and the disposition of inulin and p-aminohippurate in healthy volunteers and patients with chronic renal failure.
    Freestone S; McAuslane JA; Prescott LF
    Br J Clin Pharmacol; 1991 Oct; 32(4):495-500. PubMed ID: 1958445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term effect of propranolol therapy on renal function.
    Bauer JH; Brooks CS
    Am J Med; 1979 Mar; 66(3):405-10. PubMed ID: 433946
    [No Abstract]   [Full Text] [Related]  

  • 20. Pindolol availability in hypertensive patients with normal and impaired renal function.
    Chau NP; Weiss YA; Safar ME; Lavene DE; Georges DR; Milliez PL
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):505-10. PubMed ID: 913016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.